A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease
- PMID: 911666
- PMCID: PMC2025471
- DOI: 10.1038/bjc.1977.187
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease
Abstract
Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
